Avalo Therapeutics Inc

:CERC   3:59:51 PM EDT
2.33
+0.11 (+4.96%)
Products

Cerecor Announces FDA Acceptance Of Investigational New Drug Application For CERC-007 For Treatment Of Relapsed Or Refractory Multiple Myeloma

Published: 12/08/2020 12:27 GMT
(CERC) - Cerecor Announces FDA Acceptance of Investigational New Drug Application for Cerc-007 for Treatment of Relapsed Or Refractory Multiple Myeloma.
Cerecor Inc - Initial Data is Expected in Q1 of 2021.